Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 74,933 | 73,734 | 75,414 | 64,387 | 62,404 |
| Operating Income | -74,933 | -73,734 | -75,414 | -64,387 | -62,404 |
| Other Income | 2,947 | 5,807 | 4,780 | 5,437 | 4,056 |
| Pre-tax Income | -71,986 | -67,927 | -70,634 | -58,950 | -58,348 |
| Net Income Continuous | -71,986 | -67,927 | -70,634 | -58,950 | -58,348 |
| Net Income | $-71,986 | $-67,927 | $-70,634 | $-58,950 | $-58,348 |
| EPS Basic Total Ops | -0.52 | -0.50 | -0.52 | -0.43 | -0.49 |
| EPS Basic Continuous Ops | -0.64 | -0.61 | -0.64 | -0.59 | -0.62 |
| EPS Diluted Total Ops | -0.52 | -0.50 | -0.52 | -0.43 | -0.49 |
| EPS Diluted Continuous Ops | -0.64 | -0.61 | -0.64 | -0.59 | -0.62 |
| EPS Diluted Before Non-Recurring Items | -0.52 | -0.09 | -0.64 | N/A | N/A |
| EBITDA(a) | $-75,248 | $-75,713 | $-80,994 | $-61,200 | $-63,201 |